Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,000
Closed -$666K 133
2023
Q2
$666K Sell
3,000
-2,000
-40% -$464K 0.01% 116
2023
Q1
$1.21M Buy
+5,000
New +$1.23M 0.02% 112
2022
Q2
Sell
-2,000
Closed -$484K 173
2022
Q1
$484K Buy
+2,000
New +$460K 0.01% 145

Other funds holding AMGN

Clal Insurance's AMGN Position: Q3 2023 in Review

Clal Insurance sold out of Amgen (AMGN) in Q3 2023, closing a stake of 3,000 shares — an estimated $666K sold.

Clal Insurance first reported a position in AMGN in Q1 2022 and held it in 3 quarters. The position peaked at $1.21M in Q1 2023. 2,502 funds tracked by Wall St. Rank hold AMGN as of Q3 2023.

  • Clal Insurance reported no remaining Amgen position as of Q3 2023 after selling out during the quarter.
  • Clal Insurance sold 3,000 Amgen shares in Q3 2023, an estimated $666K.
  • Clal Insurance first reported a position in Amgen in Q1 2022 and held it in 3 quarters.
  • Clal Insurance's Amgen position peaked at $1.21M in Q1 2023.
  • 2,502 funds tracked by Wall St. Rank held Amgen as of Q3 2023.

Based on Clal Insurance's 13F filing for Q3 2023, filed 6 Nov 2023.